Option chain shows key data for Entheon Biomedical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Entheon Biomedical.

Entheon Biomedical (OTC:ENTBF) Stock, Option Chain

Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.

Cannabis

News

Penny Stocks

Psychedelics

Guidance

Small Cap

Global

Markets

ATAI

AWKNF

CYBN

ENTBF

ENVB

KONEF

MNMD

MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC.

MYCOF

NMDBF

NUMIF

FTHWF

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.

World Class Leaders In Psychedelics Form Benzinga&#39;s Psychedelic Advisory Council—Get To Know Them

FLHLF

JAGX

LOBEF

MSSTF

NVMDF

OPTHF

SILFF

TRYPF

TSLA

TWTR

CSE:ENBI

CSE:SILO

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

Biotech

Eurozone

Contracts

Asset Sales

General

CYBE

Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp.

Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon &amp; Cybin

ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP.

Entheon Biomedical Corp

WIIM

RGTI

Rigetti Computing shares are trading lower following recent strength in quantum stocks. Citron Research, on X, posted that "Small-cap quantum stocks are in a bubble" and mentioned the company.

Trading Ideas

YSXT

YSX Tech Shares Halted On Circuit Breaker To The Upside

IONQ

IonQ shares are trading lower following recent strength in quantum stocks. Citron Research, on X, posted that "Small-cap quantum stocks are in a bubble" and mentioned the company.

IPOs

YSX Tech Shares Open For Trade At $4.05/Share; IPO Priced At $4/Share On 1.25M Shares

Workiva shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $102 to $130.

Investors with a lot of money to spend have taken a bullish stance on MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MARA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for MARA Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 54% bullish and 45%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $107,870, and 9 are calls, for a total amount of $895,168.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $23.5 to $40.0 for MARA Holdings over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for MARA Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of MARA Holdings's whale trades within a strike price range from $23.5 to $40.0 in the last 30 days. 
<h3>MARA Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734536734_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.55</td>
<td>$4.4</td>
<td>$4.55</td>
<td>$25.00</td>
<td>$455.0K</td>
<td>3.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.54</td>
<td>$0.48</td>
<td>$0.54</td>
<td>$25.00</td>
<td>$102.6K</td>
<td>18.6K</td>
<td>2.0K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$0.93</td>
<td>$0.9</td>
<td>$0.9</td>
<td>$26.00</td>
<td>$90.0K</td>
<td>5.8K</td>
<td>2.2K</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$1.25</td>
<td>$1.07</td>
<td>$1.25</td>
<td>$23.50</td>
<td>$68.7K</td>
<td>868</td>
<td>560</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.6</td>
<td>$6.5</td>
<td>$6.6</td>
<td>$30.00</td>
<td>$66.0K</td>
<td>7.6K</td>
<td>133</td>
</tr>
</tbody>
</table>

<h3>About MARA Holdings</h3>
MARA Holdings Inc leverages digital asset compute to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value.
In light of the recent options history for MARA Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of MARA Holdings</h3>
<ul>
<li>With a volume of 11,309,613, the price of MARA is down -3.71% at $23.69. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 70 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest MARA Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

MARA

MARA Holdings's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PYPL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 11 uncommon options trades for PayPal Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 36% bullish and 45%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $340,200, and 7 are calls, for a total amount of $357,555.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $70.0 to $110.0 for PayPal Holdings during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for PayPal Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across PayPal Holdings's significant trades, within a strike price range of $70.0 to $110.0, over the past month.
<h3>PayPal Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734536728_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$26.45</td>
<td>$25.6</td>
<td>$25.9</td>
<td>$70.00</td>
<td>$129.4K</td>
<td>432</td>
<td align="right">50</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$26.45</td>
<td>$25.5</td>
<td>$25.5</td>
<td>$110.00</td>
<td>$102.0K</td>
<td>40</td>
<td align="right">40</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$26.0</td>
<td>$23.25</td>
<td>$23.5</td>
<td>$110.00</td>
<td>$94.0K</td>
<td>1.0K</td>
<td align="right">40</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.5</td>
<td>$12.35</td>
<td>$12.5</td>
<td>$97.50</td>
<td>$72.5K</td>
<td>1</td>
<td align="right">67</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$23.95</td>
<td>$23.6</td>
<td>$23.9</td>
<td>$110.00</td>
<td>$71.7K</td>
<td>746</td>
<td align="right">130</td>
</tr>
</tbody>
</table>

<h3>About PayPal Holdings</h3>
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 426 million active accounts at the end of 2023. The company also owns Venmo, a person-to-person payment platform.
In light of the recent options history for PayPal Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>PayPal Holdings's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,298,411, with PYPL's price down by -0.48%, positioned at $90.42.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 49 days.</li>
</ul>
<h3>Expert Opinions on PayPal Holdings</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $107.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $100. 
&#x2A; An analyst from Macquarie persists with their Outperform rating on PayPal Holdings, maintaining a target price of $115. 
&#x2A; An analyst from Wolfe Research has elevated its stance to Outperform, setting a new price target at $107. 
&#x2A; An analyst from B of A Securities upgraded its action to Buy with a price target of $103. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for PayPal Holdings, targeting a price of $110. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest PayPal Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

PYPL

What the Options Market Tells Us About PayPal Holdings

Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 22% leaning bullish and 77% bearish. Among these notable options, 2 are puts, totaling $53,630, and 7 are calls, amounting to $255,390.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $45.0 and $65.0 for Viking Therapeutics, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Viking Therapeutics stands at 1159.25, with a total volume reaching 3,361.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Viking Therapeutics, situated within the strike price corridor from $45.0 to $65.0, throughout the last 30 days.
<h3>Viking Therapeutics 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734536723_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.4</td>
<td>$5.1</td>
<td>$5.2</td>
<td>$60.00</td>
<td>$52.0K</td>
<td align="right">829</td>
<td align="right">273</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.3</td>
<td>$5.2</td>
<td>$5.2</td>
<td>$60.00</td>
<td>$52.0K</td>
<td align="right">829</td>
<td align="right">173</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.6</td>
<td>$3.2</td>
<td>$3.3</td>
<td>$45.00</td>
<td>$35.6K</td>
<td align="right">271</td>
<td align="right">280</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.3</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$45.00</td>
<td>$33.6K</td>
<td align="right">271</td>
<td align="right">822</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.5</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$45.00</td>
<td>$31.0K</td>
<td align="right">271</td>
<td align="right">578</td>
</tr>
</tbody>
</table>

<h3>About Viking Therapeutics</h3>
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
After a thorough review of the options trading surrounding Viking Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Viking Therapeutics</h3>
<ul>
<li>With a trading volume of 3,362,736, the price of VKTX is down by -9.27%, reaching $42.37.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 49 days from now.</li>
</ul>
<h3>Expert Opinions on Viking Therapeutics</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $97.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Overweight, adjusting the price target to $74. 
&#x2A; In a cautious move, an analyst from HC Wainwright &amp; Co. downgraded its rating to Buy, setting a price target of $102. 
&#x2A; An analyst from HC Wainwright &amp; Co. downgraded its action to Buy with a price target of $102. 
&#x2A; Reflecting concerns, an analyst from B. Riley Securities lowers its rating to Buy with a new price target of $109. 
&#x2A; An analyst from HC Wainwright &amp; Co. downgraded its action to Buy with a price target of $102. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Viking Therapeutics options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

VKTX

Smart Money Is Betting Big In VKTX Options

VUZI

Vuzix shares are trading higher after the company announced it entered into a strategic agreement with Augmex and has shipped an initial six-figure order.

Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) has outperformed the market over the past 10 years by 1.49% on an annualized basis producing an average annual return of 12.78%. Currently, Allison Transmission has a market capitalization of $9.75 billion. 
Buying $1000 In ALSN: If an investor had bought $1000 of ALSN stock 10 years ago, it would be worth $3,361.85 today based on a price of $112.50 for ALSN at the time of writing.
<h3>Allison Transmission's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734536710_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALSN

Here's How Much $1000 Invested In Allison Transmission 10 Years Ago Would Be Worth Today

Citigroup analyst Patrick Cunningham maintains Ecovyst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECVT#NYSE">ECVT</a>) with a Buy and raises the price target from $8 to $9.

Price Target

Analyst Ratings

ECVT

Citigroup Maintains Buy on Ecovyst, Raises Price Target to $9

EnerSys shares are trading higher after the company raised its Q3 and FY25 adjusted EPS guidance above estimates.

NOTV

Inotic shares are trading lower after the company announced a public offering of 6 million shares priced at $4.25 per unit.

RBC Capital analyst Leonid Timashev maintains Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Outperform and raises the price target from $80 to $82.

CYTK

RBC Capital Maintains Outperform on Cytokinetics, Raises Price Target to $82

Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) with a Buy and lowers the price target from $98 to $92.

Citigroup Maintains Buy on DuPont de Nemours, Lowers Price Target to $92

RDZN

Roadzen shares are trading higher after the company announced it expanded its AI-based claims contract with a top 10 Indian insurer client.

NBA Hall of Famer and analyst Shaquille O'Neal has added a custom Lucid Air from Lucid Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) to the list of vehicles he owns, which includes several Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Cybertruck <a href="https://www.benzinga.com/general/entertainment/24/09/40758484/nba-legend-shaq-shows-off-his-new-widebody-carbon-fiber-tesla-cybertruck-elon-musk-has-a-on">electric pickup trucks.</a>
What Happened: O'Neal, also known as Shaq, is a fan of owning multiple vehicles, especially when he <a href="https://www.benzinga.com/general/entertainment/24/08/40413674/nba-legend-shaq-missed-his-tesla-cybertruck-so-much-instead-of-shipping-it-from-vegas-to-at">likes them so much.</a>
The 7'1" former NBA star often needs to have his vehicles customized to make them more comfortable for his larger than life frame. That's what happened with one of his newest vehicles, a Lucid Air.
Shaq had a four-door Lucid Air turned into a two-door coupe to better fit inside, as <a href="https://insideevs.com/news/744608/shaq-lucid-air-coupe-custom/">reported </a>by InsideEVs. The customization job was done by West Coast Customs, a body shop made famous on the former MTV show "Pimp My Ride." The shop often works with celebrities and global brands on custom jobs.
Images <a href="https://www.instagram.com/p/DDshjRWywyk/">shared </a>on Instagram show the custom Lucid Air has larger doors than the retail model along with other modifications. As with many Shaq vehicles, modifications often include new custom tires. The front of the car also features the word "Diesel," a reference to Shaq's DJ Diesel music personality, replacing the word "Lucid."
Read Also: <a href="https://www.benzinga.com/general/sports/24/09/40866143/shaquille-oneal-reflects-on-divorce-fatherhood-and-personal-accountability-i-was-lost-76-000-squar">Shaquille O&#8217;Neal Reflects On Divorce, Fatherhood And Personal Accountability: &#8216;I Was Lost. 76,000 Square Foot House By Yourself&#8217;</a>
Why It's Important: Shaq owns at least two Cybertrucks, which feature several customizations, but none as big a job needed to switch the Lucid Air from a four-door to a two-door.
One of the Cybertruck custom jobs caught the attention of Tesla CEO Elon Musk, who responded to a photo of it on social media platform X.
Shaq also famously bought two Lamborghini Gallardos previously for $600,000 and had them spliced together to make a larger version of the vehicle, as reported by <a href="https://jalopnik.com/remember-when-shaquille-o-neal-had-a-lengthened-lamborg-1851621497">Jalopnik</a>.
While Shaq wanted a two-door electric coupe for himself, Lucid will likely not be making a similar model for the public. Many automotive companies are moving towards SUVs, including three-row SUVs due to customer demand.
Lucid opened orders for the Lucid Gravity SUV on Nov. 7, it's second vehicle launch.
The company delivered 7,124 vehicles through the first <a href="https://www.benzinga.com/news/earnings/24/11/41826774/lucid-q3-earnings-revenue-beat-eps-beat-on-track-to-produce-9k-vehicles-in-2024">three quarters of the year</a>, with guidance of 9,000 vehicle deliveries in 2024.
Having Shaq as one of their customers could help Lucid's brand awareness and provide some free marketing along the way. The fact that Shaq owns vehicles from both Tesla and Lucid could also amplify the rivalry between the two electric vehicle companies if anyone ever asks the NBA Hall of Famer which model and company he prefers.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/management/24/06/39364585/lucid-vs-tesla-ceo-says-companys-technology-is-a-number-of-years-ahead-of-ev-leader">Lucid Vs. Tesla: CEO Says Company&#8217;s Technology Is &#8216;A Number Of Years Ahead&#8217; Of EV Leader</a></li>
</ul>
Photo Shutterstock

Sports

LCID

Shaq Goes From Custom Cybertruck To Custom Lucid Air: Here's What He Changed On His New EV

Citigroup analyst Patrick Cunningham maintains Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) with a Neutral and lowers the price target from $51 to $41.

Citigroup Maintains Neutral on Dow, Lowers Price Target to $41

RBC Capital analyst Mike Dahl maintains JELD-WEN Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) with a Underperform and lowers the price target from $9 to $8.

JELD

RBC Capital Maintains Underperform on JELD-WEN Holding, Lowers Price Target to $8

As markets brace for the Federal Reserve's final policy meeting of the year, scheduled at 2:00 p.m. Wednesday, Goldman Sachs highlighted 20 exchange-traded funds (ETFs) that have historically shown outsized <a href="https://www.benzinga.com/topic/federal-reserve">moves around Fed decision days</a>.
While a 25-basis-point rate cut to a target range of 4.25%-4.50% is widely anticipated, the market's focus is on the Fed's forward guidance, particularly the Summary of Economic Projections (SEP) and the updated &#8220;dot plot.&#8221;
Following December's expected cut, Goldman Sachs projects a more measured pace of easing next year, forecasting rate cuts in March, June, and September, with the terminal rate seen at 3.50%-3.75%.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42554114/all-eyes-on-december-fed-meeting-as-traders-await-interest-rate-projections">All Eyes On December Fed Meeting As Traders Await Interest Rate Projections</a>
<h3 class="wp-block-heading">Market Dynamics Around Fed Days</h3>
U.S. equity markets have displayed strong short-term gains during Fed meeting weeks in 2024. 
Investors employing a simple strategy of buying the S&amp;P 500 index at market close before a Federal Open Market Committee (FOMC) announcement and selling at close the following day have captured median returns of 1.1% across the past seven meetings.
Yet those extending the trade horizon to 15 sessions post-Fed meeting have enjoyed significantly larger average gains of 3.29%, more than double the short-term returns. Notably, every Fed meeting this year has resulted in positive 15-day returns.
"We observe that U.S. banking ETFs, such as SPDR S&amp;P Bank ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBE#NYSE">KBE</a>) and SPDR S&amp;P Regional Banking ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>), have seen unusually large moves on FOMC days since 2022" Goldman analysts wrote in a recent note.
For bond-focused investors, the report highlights consistent post-meeting gains in high-yield and investment-grade ETFs like iShares iBoxx $ High Yield Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYG#NYSE">HYG</a>) and iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQD#NYSE">LQD</a>).
Meanwhile, energy-focused ETFs, such as the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>), have seen negative reactions. 
<h3 class="wp-block-heading">ETFs Showing Heightened Fed-Day Moves</h3>
Here's Goldman Sachs' list of 20 ETFs with the largest absolute moves – which include both positive and negative swing – on FOMC days:
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>ETF Name</th>
<th>Focus</th>
<th>Average Absolute Move on FOMC since 2022</th>
<th>Average Absolute Move (Last 3 FOMC events)</th>
</tr>
</thead>
<tbody>
<tr>
<td>SPDR S&amp;P Regional Banking ETF </td>
<td>Regional Banking</td>
<td>2.5%</td>
<td>1.5%</td>
</tr>
<tr>
<td>VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>)</td>
<td>Semiconductor</td>
<td>2.4%</td>
<td>3.7%</td>
</tr>
<tr>
<td>iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>)</td>
<td>Semiconductor</td>
<td>2.4%</td>
<td>3.3%</td>
</tr>
<tr>
<td>SPDR S&amp;P Bank ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBE#NYSE">KBE</a>)</td>
<td>US Large Banks</td>
<td>2.2%</td>
<td>1.3%</td>
</tr>
<tr>
<td>SPDR S&amp;P Biotech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XBI#NYSE">XBI</a>)</td>
<td>Biotech</td>
<td>2.0%</td>
<td>0.3%</td>
</tr>
<tr>
<td>United States Oil Fund </td>
<td>Oil</td>
<td>1.9%</td>
<td>2.0%</td>
</tr>
<tr>
<td>Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>Technology</td>
<td>1.9%</td>
<td>2.3%</td>
</tr>
<tr>
<td>iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>)</td>
<td>Silver</td>
<td>1.7%</td>
<td>2.4%</td>
</tr>
<tr>
<td>Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)</td>
<td>Nasdaq 100</td>
<td>1.7%</td>
<td>1.7%</td>
</tr>
<tr>
<td>Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>Discretionary</td>
<td>1.6%</td>
<td>1.0%</td>
</tr>
<tr>
<td>iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>)</td>
<td>Russell 2000</td>
<td>1.5%</td>
<td>0.3%</td>
</tr>
<tr>
<td>SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)</td>
<td>S&amp;P 500</td>
<td>1.2%</td>
<td>0.9%</td>
</tr>
<tr>
<td>Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>)</td>
<td>S&amp;P 500</td>
<td>1.2%</td>
<td>0.9%</td>
</tr>
<tr>
<td>Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>Financial</td>
<td>1.1%</td>
<td>0.7%</td>
</tr>
<tr>
<td>SPDR Gold Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>)</td>
<td>Gold</td>
<td>0.9%</td>
<td>1.4%</td>
</tr>
<tr>
<td>iShares J.P. Morgan USD Emerging Markets Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMB#NASDAQ">EMB</a>)</td>
<td>EM Bond</td>
<td>0.8%</td>
<td>0.6%</td>
</tr>
<tr>
<td>iShares iBoxx $ High Yield Corporate Bond ETF </td>
<td>HY Corp Bond</td>
<td>0.6%</td>
<td>0.3%</td>
</tr>
<tr>
<td>iShares iBoxx $ Investment Grade Corporate Bond ETF </td>
<td>IG Corp Bond</td>
<td>0.6%</td>
<td>0.7%</td>
</tr>
<tr>
<td>iShares 7-10 Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEF#NASDAQ">IEF</a>)</td>
<td>7-10 Year Treasury</td>
<td>0.6%</td>
<td>0.7%</td>
</tr>
<tr>
<td>iShares TIPS Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIP#NYSE">TIP</a>)</td>
<td>TIPS Bond</td>
<td>0.5%</td>
<td>0.4%</td>
</tr>
<tr>
<td>Average</td>
<td></td>
<td>1.5%</td>
<td>1.3%</td>
</tr>
</tbody>
</table>
</figure>
Check Out: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42539116/fed-meetings-made-stock-traders-richer-in-2024-could-wednesday-bring-last-big-rally">Fed Meetings Made Stock Traders Richer In 2024: Could Wednesday Bring Last Big Rally?</a></li>
</ul>
Image: Shutterstock

Analyst Color

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Specialty ETFs

New ETFs

Emerging Market ETFs

Currency ETFs

Previews

Econ #s

Economics

Federal Reserve

ETFs

iShares JPMorgan USD Emerging Markets Bond Fund

iShares Trust Barclays 7-10 Year Treasury Bond Fund

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Select Sector SPDR-Consumer Discretionary

20 ETFs Primed For Unusually Big Swings On Fed Meeting Days

RBC downgrades Nevro to sector perform, cites salesforce turnaround

RBC downgrades 89Bio to sector perform, cites fewer near-term catalysts

Entheon Biomedical Corp. (TSE:ENBI) has released an update. Entheon Biomedical Corp., a biotech firm working on addiction and substance use disorde...

Entheon Biomedical's Strategic Financing Initiative

Entheon Biomedical Corp. (TSE:ENBI) has released an update. Entheon Biomedical Corp. has successfully completed a private placement, raising $147,5...

Entheon Biomedical Completes $147.5K Private Placement

Entheon Biomedical (TSE:ENBI) has released an update. Canadian biotech firm Entheon Biomedical is launching a private placement financing to raise ...

Entheon Biomedical Announces New Private Placement Financing

NVRO

REGN

Entheon Biomedical

Comments

Entheon Biomedical

Entheon Biomedical (ENTBF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga